Her main research concerns Virology, Lentivirus, Drug resistance, Genotype and Viral load. Her Virology study combines topics in areas such as Integrase, Acquired immunodeficiency syndrome and Immunology. Her biological study deals with issues like Internal medicine, which deal with fields such as Ritonavir.
Her Lentivirus study is associated with Virus. The various areas that Carmen de Mendoza examines in her Drug resistance study include Gastroenterology, Sida, Reverse-transcriptase inhibitor and Polymerase chain reaction, Nested polymerase chain reaction. Her work on BDNA test as part of general Viral load research is often related to Dried blood, thus linking different fields of science.
Virology, Drug resistance, Immunology, Internal medicine and Virus are her primary areas of study. She focuses mostly in the field of Virology, narrowing it down to topics relating to Genotype and, in certain cases, Integrase. Her biological study spans a wide range of topics, including Protease inhibitor, Resistance mutation, Reverse transcriptase, Mutation and Regimen.
Many of her research projects under Internal medicine are closely connected to In patient with In patient, tying the diverse disciplines of science together. Her research in Virus intersects with topics in Hepatitis B, Antibody and Drug. Her research investigates the connection between Viral disease and topics such as Acquired immunodeficiency syndrome that intersect with problems in Epidemiology.
Carmen de Mendoza spends much of her time researching Virology, Internal medicine, HTLV-1 Infection, In patient and Virus. Her Virology research is multidisciplinary, incorporating perspectives in Integrase inhibitor, Drug resistance and Genotype. Her study looks at the relationship between Drug resistance and topics such as Rilpivirine, which overlap with Intensive care medicine.
In her study, Hepatitis C virus is inextricably linked to Gastroenterology, which falls within the broad field of Internal medicine. Her Virus study combines topics from a wide range of disciplines, such as Hepatitis B, Hepatitis C and Hepatocellular carcinoma. She works mostly in the field of Tropical spastic paraparesis, limiting it down to topics relating to Transmission and, in certain cases, Acquired immunodeficiency syndrome.
The scientist’s investigation covers issues in Internal medicine, Hepatitis C, Incidence, HTLV-1 Infection and Human T-lymphotropic virus 1. Her Internal medicine research incorporates themes from Coinfection and Serology. Her Coinfection research includes elements of Treatment outcome, Viremia, Acquired immunodeficiency syndrome, Viral load and Retrospective cohort study.
Virology covers Carmen de Mendoza research in Hepatitis C. Her studies deal with areas such as Global health, Epidemiology, Young adult and Environmental health as well as Incidence. Her HTLV-1 Infection research integrates issues from Outcome assessment, Dialysis, HTLV-I infections and Transplantation.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Prevalence of Drug-Resistant HIV-1 Variants in Untreated Individuals in Europe: Implications for Clinical Management
Annemarie M. J. Wensing;David A. van de Vijver;Gioacchino Angarano;Birgitta Åsjö.
The Journal of Infectious Diseases (2005)
Tracing the HIV-1 subtype B mobility in Europe: a phylogeographic approach
Dimitrios Paraskevis;Dimitrios Paraskevis;Oliver Pybus;Gkikas Magiorkinis;Angelos Hatzakis.
Natural pregnancies in HIV-serodiscordant couples receiving successful antiretroviral therapy.
Pablo Barreiro;Jorge del Romero;Manuel Leal;Victoria Hernando.
Journal of Acquired Immune Deficiency Syndromes (2006)
Impact of Human Immunodeficiency Virus Type 1 (HIV-1) Genetic Diversity on Performance of Four Commercial Viral Load Assays: LCx HIV RNA Quantitative, AMPLICOR HIV-1 MONITOR v1.5, VERSANT HIV-1 RNA 3.0, and NucliSens HIV-1 QT
Priscilla Swanson;Carmen de Mendoza;Yagnya Joshi;Alan Golden.
Journal of Clinical Microbiology (2005)
Evaluation of Eight Different Bioinformatics Tools To Predict Viral Tropism in Different Human Immunodeficiency Virus Type 1 Subtypes
Carolina Garrido;Vanessa Roulet;Natalia Chueca;Eva Poveda.
Journal of Clinical Microbiology (2008)
The calculated genetic barrier for antiretroviral drug resistance substitutions is largely similar for different HIV-1 subtypes
David A van de Vijver;Annemarie M J Wensing;Gioacchino Angarano;Birgitta Asjö.
Journal of Acquired Immune Deficiency Syndromes (2006)
Dried Blood Spots Perform Well in Viral Load Monitoring of Patients Who Receive Antiretroviral Treatment in Rural Tanzania
Asgeir Johannessen;Carolina Garrido;Natalia Zahonero;Leiv Sandvik.
Clinical Infectious Diseases (2009)
Prevalence of X4 tropic viruses in patients recently infected with HIV-1 and lack of association with transmission of drug resistance
Carmen de Mendoza;Carmen Rodriguez;Federico García;José M. Eiros.
Journal of Antimicrobial Chemotherapy (2007)
Prevalence of transmitted HIV-1 drug resistance and the role of resistance algorithms: data from seroconverters in the CASCADE collaboration from 1987 to 2003.
Bernard Masquelier;Krishnan Bhaskaran;Deenan Pillay;Robert Gifford.
Journal of Acquired Immune Deficiency Syndromes (2005)
Drug resistance in patients experiencing early virological failure under a triple combination including indinavir.
Oscar Gallego;Carmen De Mendoza;Maria Jesus Perez-Elias;Josep Maria Guardiola.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: